Bonnie H. Anderson's most recent trade in Bruker Corp was a trade of 3,298 Common Stock done . Disclosure was reported to the exchange on Feb. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bruker Corp | Bonnie H. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 3,298 | 13,327 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | Bonnie Anderson H. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 2,377 | 10,029 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.72 per share. | 02 Jun 2023 | 1,304 | 41,377 (0%) | 0% | 26.7 | 34,843 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2023 | 34,000 | 34,117 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 14 Apr 2023 | 34,000 | 76,681 (0%) | 0% | 5.6 | 190,740 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 22.04 per share. | 14 Apr 2023 | 34,000 | 42,681 (0%) | 0% | 22.0 | 749,357 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 34,000 | 68,117 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 22.76 per share. | 15 Mar 2023 | 34,000 | 53,967 (0%) | 0% | 22.8 | 773,888 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 15 Mar 2023 | 34,000 | 87,967 (0%) | 0% | 5.6 | 190,740 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.10 per share. | 02 Mar 2023 | 8,994 | 53,967 (0%) | 0% | 24.1 | 216,755 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 34,000 | 102,117 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 17 Jan 2023 | 34,000 | 96,961 (0%) | 0% | 5.6 | 190,740 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 17 Jan 2023 | 29,506 | 67,455 (0%) | 0% | 26.3 | 776,111 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 26.64 per share. | 17 Jan 2023 | 4,494 | 62,961 (0%) | 0% | 26.6 | 119,726 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 25.13 per share. | 11 Jan 2023 | 63,247 | 62,961 (0%) | 0% | 25.1 | 1,589,195 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2023 | 63,247 | 26,753 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.34 per share. | 11 Jan 2023 | 63,247 | 126,208 (0%) | 0% | 14.3 | 906,962 | Common Stock |
| Bruker Corp | Bonnie H. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 1,970 | 7,652 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.14 per share. | 02 Dec 2022 | 2,042 | 62,961 (0%) | 0% | 29.1 | 59,504 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 50,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.34 per share. | 01 Dec 2022 | 50,000 | 115,003 (0%) | 0% | 14.3 | 717,000 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 28.60 per share. | 01 Dec 2022 | 45,460 | 65,003 (0%) | 0% | 28.6 | 1,300,301 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 27.81 per share. | 01 Dec 2022 | 34,540 | 110,463 (0%) | 0% | 27.8 | 960,447 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 01 Dec 2022 | 30,000 | 145,003 (0%) | 0% | 5.6 | 168,300 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 30,000 | 136,117 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2022 | 9,244 | 300,756 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.05 per share. | 13 Oct 2022 | 9,244 | 76,091 (0%) | 0% | 9.0 | 83,658 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.86 per share. | 13 Oct 2022 | 1,844 | 66,847 (0%) | 0% | 8.9 | 16,338 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2022 | 1,844 | 0 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.18 per share. | 02 Sep 2022 | 2,042 | 65,003 (0%) | 0% | 19.2 | 39,166 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 27.71 per share. | 05 Aug 2022 | 76,917 | 157,426 (0%) | 0% | 27.7 | 2,131,370 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 27.24 per share. | 05 Aug 2022 | 39,231 | 118,195 (0%) | 0% | 27.2 | 1,068,578 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 27.82 per share. | 05 Aug 2022 | 5,769 | 112,426 (0%) | 0% | 27.8 | 160,497 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.23 per share. | 02 Jun 2022 | 2,042 | 67,045 (0%) | 0% | 18.2 | 37,226 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.47 per share. | 01 May 2022 | 736 | 85,952 (0%) | 0% | 20.5 | 15,066 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 32,195 | 32,195 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 17,667 | 86,688 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.84 per share. | 02 Mar 2022 | 4,521 | 69,021 (0%) | 0% | 27.8 | 125,865 | Common Stock |
| Bruker Corp | Bonnie H. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2022 | 1,841 | 5,682 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 11,286 | 1,844 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.86 per share. | 09 Dec 2021 | 11,286 | 73,542 (0%) | 0% | 8.9 | 99,994 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.22 per share. | 02 Dec 2021 | 2,288 | 62,256 (0%) | 0% | 39.2 | 89,735 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 50.18 per share. | 17 Sep 2021 | 2,600 | 217,478 (0%) | 0% | 50.2 | 130,478 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 50.03 per share. | 10 Sep 2021 | 1,900 | 220,078 (0%) | 0% | 50.0 | 95,050 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.97 per share. | 02 Sep 2021 | 2,288 | 64,544 (0%) | 0% | 53.0 | 121,195 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.07 per share. | 02 Jun 2021 | 2,288 | 189,725 (0%) | 0% | 36.1 | 82,528 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2021 | 14,065 | 166,117 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 17 May 2021 | 14,065 | 192,013 (0%) | 0% | 5.6 | 78,905 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.15 per share. | 02 Mar 2021 | 6,320 | 177,948 (0%) | 0% | 62.2 | 392,788 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 20,000 | 184,268 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.30 per share. | 24 Feb 2021 | 39,488 | 164,268 (0%) | 0% | 62.3 | 2,460,102 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2021 | 18,541 | 180,182 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 13 Jan 2021 | 18,541 | 222,297 (0%) | 0% | 5.6 | 104,015 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 51.26 per share. | 13 Jan 2021 | 12,177 | 203,756 (0%) | 0% | 51.3 | 624,180 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 50.64 per share. | 13 Jan 2021 | 6,364 | 215,933 (0%) | 0% | 50.6 | 322,283 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.86 per share. | 11 Jan 2021 | 65,182 | 268,938 (0%) | 0% | 8.9 | 577,513 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 65,182 | 13,130 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 50.90 per share. | 11 Jan 2021 | 34,257 | 215,253 (0%) | 0% | 50.9 | 1,743,839 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 49.81 per share. | 11 Jan 2021 | 25,351 | 249,510 (0%) | 0% | 49.8 | 1,262,713 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 20,354 | 198,723 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 11 Jan 2021 | 20,354 | 224,110 (0%) | 0% | 5.6 | 114,186 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 50.29 per share. | 11 Jan 2021 | 15,568 | 204,156 (0%) | 0% | 50.3 | 782,982 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 51.56 per share. | 11 Jan 2021 | 11,497 | 203,756 (0%) | 0% | 51.6 | 592,751 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 5,923 | 219,077 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 11 Jan 2021 | 5,923 | 274,861 (0%) | 0% | 5.6 | 33,228 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 49.77 per share. | 11 Jan 2021 | 4,386 | 219,724 (0%) | 0% | 49.8 | 218,311 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 51.20 per share. | 11 Jan 2021 | 400 | 203,756 (0%) | 0% | 51.2 | 20,480 | Common Stock |
| Bruker Corp | Bonnie H. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 2,302 | 3,841 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 29 Dec 2020 | 25,000 | 203,756 (0%) | 0% | 4 | 100,000 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2020 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.68 per share. | 29 Dec 2020 | 6,313 | 178,756 (0%) | 0% | 2.7 | 16,919 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2020 | 6,313 | 0 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.08 per share. | 02 Dec 2020 | 1,976 | 172,443 (0%) | 0% | 55.1 | 108,838 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2020 | 22,906 | 47,906 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2020 | 22,906 | 47,906 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2020 | 22,906 | 174,419 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2020 | 22,906 | 197,325 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2020 | 20,000 | 78,312 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.86 per share. | 10 Nov 2020 | 20,000 | 240,231 (0%) | 0% | 8.9 | 177,200 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.02 per share. | 10 Nov 2020 | 8,218 | 223,650 (0%) | 0% | 43.0 | 353,555 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.01 per share. | 10 Nov 2020 | 4,370 | 231,868 (0%) | 0% | 42.0 | 183,582 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.99 per share. | 10 Nov 2020 | 3,993 | 236,238 (0%) | 0% | 41.0 | 163,675 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.61 per share. | 10 Nov 2020 | 3,419 | 220,231 (0%) | 0% | 43.6 | 149,117 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 38.00 per share. | 08 Oct 2020 | 50,000 | 220,231 (0%) | 0% | 38 | 1,900,000 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2020 | 50,000 | 98,312 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.86 per share. | 08 Oct 2020 | 50,000 | 270,231 (0%) | 0% | 8.9 | 443,000 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2020 | 20,000 | 148,312 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.86 per share. | 10 Sep 2020 | 20,000 | 240,231 (0%) | 0% | 8.9 | 177,200 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 30.61 per share. | 10 Sep 2020 | 13,393 | 226,838 (0%) | 0% | 30.6 | 409,934 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 31.47 per share. | 10 Sep 2020 | 6,607 | 220,231 (0%) | 0% | 31.5 | 207,926 | Common Stock |
| Bruker Corp | Bonnie H. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2020 | 1,539 | 1,539 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.16 per share. | 02 Sep 2020 | 1,976 | 220,231 (0%) | 0% | 34.2 | 67,500 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2020 | 25,000 | 247,207 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2020 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2020 | 25,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2020 | 25,000 | 222,207 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 20,000 | 168,312 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.22 per share. | 06 Aug 2020 | 20,000 | 222,207 (0%) | 0% | 32.2 | 644,478 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.86 per share. | 06 Aug 2020 | 20,000 | 242,207 (0%) | 0% | 8.9 | 177,200 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2020 | 11,365 | 188,312 | - | - | Stock Option (right to buy) |